Balapadang, R.N. and Sudarjat, H. 2024. Potential of Beta-Hydroxybutyrate (BHB) in the Management of Type 2 Diabetes and Risk of Ketoacidosis in Diabetic Patients. Journal of Pharmaceutical and Sciences. 7, 4 (Oct. 2024), 562–570. DOI:https://doi.org/10.36490/journal-jps.com.v7i4.520.